BioMarin Pharma (BMRN) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. OIG
5. NRIX
6. SUNS
7. ACI
8. SPY
9. SNDX
10. HUM

Go back to BioMarin Pharma (BMRN) Tops Q3 EPS by 6c

BioMarin (BMRN) PT Lifted to $87 at Jefferies Posts Q3

October 24, 2014 8:24 AM EDT

Jefferies analyst Eun Yang reiterated a Buy rating and boosted his price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $87.00 (from $84.00) following better-than-expected product sales.

Yang commented, "Better-than-expected 3Q products sales led to ~1-3% upside revision to FY14 revenue guidance (+28-29% y/y).... More